form8k.htm



 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  October 7, 2008 (May 30, 2008)
 
BlackRock Health Sciences Trust
(Exact name of registrant as specified in its charter)
 
DELAWARE
  
 
811-21702
  
 
20-2433262
 
(State or other jurisdiction
  
 
(Commission File Number)
  
 
(I.R.S. Employer
 
of incorporation)
 
      
 
Identification No.)
 
 
 
40 East 52nd Street
 
  
 
10022
 
 
New York, New York
 
    
 
(Address of principal executive offices)
 
  
 
(Zip Code)
 
 
Registrant’s telephone number, including area code:  (212) 810-5300
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
     
 
o
  
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
 
o
  
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
 
o
  
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))
     
 
o
  
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13-4(c))
 
 
 
 
 

 

Item 7.01
Regulation FD Disclosure.
 

 
On May 30, 2008, the Board of Directors of BlackRock Health Sciences Trust (the "Fund") amended and restated in its entirety the bylaws of the Fund (the "Amended and Restated Bylaws") to (i) conform all the bylaws across all the funds in the BlackRock closed-end fund complex, (ii) to ensure that the listed securities of the Fund are eligible for participation in the Direct Registration System, and (iii) to include advance notice provisions with respect to shareholder proposals to nominate directors or conduct other business at a meeting of the Fund's shareholders (the "Advance Notice Provisions").  The Advance Notice Provisions will take effect for any shareholder meetings occurring after the 2008 annual shareholder meeting.  The Amended and Restated Bylaws were deemed effective May 29, 2008.
 
The foregoing description of the Amended and Restated Bylaws does not purport to be complete and is qualified in its entirety by reference to the full text of the Amended and Restated Bylaws, which are attached hereto as Exhibit 3.1 and are incorporated herein by reference.
 
Item 9.01
Financial Statements and Exhibits.

(d)
Exhibits

3.1
Amended and Restated Bylaws of BlackRock Health Sciences Trust

 
 
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
           
   
 
BlackRock Health Sciences Trust
  
       
   
 
By:
  
 
/s/ Howard B. Surloff
   
Name:
 
  
Howard B. Surloff
 
   
Title:
  
Secretary
 
DATE:  October 7, 2008
 
        
 

 



 
 
 

EXHIBIT INDEX

Exhibit No.
Description
 
3.1
 
Amended and Restated Bylaws of BlackRock Health Sciences Trust